Lv13
20 积分 2024-02-23 加入
Gut microbiota and metabolites of cirrhotic portal hypertension: a novel target on the therapeutic regulation
1小时前
已完结
Therapeutic potential of rifaximin in liver diseases
1小时前
已完结
The burden of hepatic encephalopathy and the use of albumin as a potential treatment
22小时前
已完结
Psychometric hepatic encephalopathy score (PHES) – when, how, why, and why not: a guide for the unfamiliar
23小时前
已完结
Hepatic encephalopathy in cirrhosis: therapies and developments
1天前
已完结
Rifaximin treatment shapes a unique metagenome‐metabolism network in patients with decompensated cirrhosis
2天前
已完结
Rifaximin treatment shapes a unique metagenome‐metabolism network in patients with decompensated cirrhosis
2个月前
已完结
Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis
3个月前
已完结
Oral LPCN 1148 improves sarcopenia and hepatic encephalopathy in male patients with cirrhosis: A randomized, placebo-controlled phase 2 trial
3个月前
已完结
QuickStroop Predicts Time to Development of Overt Hepatic Encephalopathy and Related Hospitalizations in Patients With Cirrhosis
8个月前
已完结
皖公网安备34019202002308
